![](/img/cover-not-exists.png)
PIN67 MODELING G-DRG REVENUE WHEN HOSPITALIZATION DURATION FROM CLINICAL TRIALS IS AVAILABLE:THE CASE OF DORIPENEM VERSUS IMIPENEM IN TREATING VENTILATOR-ASSOCIATED PNEUMONIA (VAP) IN GERMANY
De Cock, E, Gast, C, Berndt, K, Kubitz, NVolume:
13
Language:
english
Journal:
Value in Health
DOI:
10.1016/S1098-3015(11)72864-9
Date:
November, 2010
File:
PDF, 76 KB
english, 2010